Werewolf Therapeutics, Inc. (HOWL)
Largest Insider Buys in Sector
HOWL Stock Price History Chart
HOWL Stock Performance
About Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Insider Activity of Werewolf Therapeutics, Inc.
Over the last 12 months, insiders at Werewolf Therapeutics, Inc. have bought $0 and sold $0 worth of Werewolf Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Werewolf Therapeutics, Inc. have bought $75.84M and sold $40,242 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,853,000 shares for transaction amount of $4.1M was made by RA CAPITAL MANAGEMENT, L.P. (director) on 2023‑01‑06.
List of Insider Buy and Sell Transactions, Werewolf Therapeutics, Inc.
| 2023-01-06 | RA CAPITAL MANAGEMENT, L.P. | director | 1.85M 5.9218% | $2.21 | $4.1M | +17.33% | ||
| 2021-12-15 | Sale | Leonard Reid | Chief Operating Officer | 3,000 0.0157% | $13.41 | $40,242 | -65.47% | |
| 2021-06-16 | RA CAPITAL MANAGEMENT, L.P. | 9,285 0.0512% | $13.37 | $124,140 | +0.29% | |||
| 2021-06-15 | RA CAPITAL MANAGEMENT, L.P. | 7,958 0.0452% | $12.95 | $103,056 | +6.61% | |||
| 2021-06-14 | RA CAPITAL MANAGEMENT, L.P. | 306,055 1.727% | $12.75 | $3.9M | +7.62% | |||
| 2021-05-04 | GADICKE ANSBERT | 10 percent owner | 245,000 1.3777% | $16.00 | $3.92M | -12.48% | ||
| 2021-05-04 | EVNIN LUKE | 150,799 0.848% | $16.00 | $2.41M | -12.48% | |||
| 2021-05-04 | RA CAPITAL MANAGEMENT, L.P. | 1.72M 9.6439% | $16.00 | $27.44M | -12.48% | |||
| 2021-05-04 | MPM BioVentures 2014, L.P. | 10 percent owner | 125,759 0.7072% | $16.00 | $2.01M | -12.48% | ||
| 2021-05-04 | Flynn James E | 10 percent owner | 800,000 4.4986% | $16.00 | $12.8M | -12.48% | ||
| 2021-05-04 | Taiho Ventures LLC | 10 percent owner | 312,500 1.7573% | $16.00 | $5M | -12.48% | ||
| 2021-05-04 | Asanuma Sakae | 312,500 1.7573% | $16.00 | $5M | -12.48% | |||
| 2021-05-04 | Lazarus Alon | 400,000 2.2493% | $16.00 | $6.4M | -12.48% | |||
| 2021-05-04 | Arkin Bio Ventures 2 L.P. | 10 percent owner | 400,000 2.2493% | $16.00 | $6.4M | -12.48% | ||
| 2021-05-04 | Longwood Fund III GP, LLC | 10 percent owner | 250,000 1.4058% | $16.00 | $4M | -12.48% | ||
| 2021-05-04 | Sphera Global Healthcare Management LP | 10 percent owner | 475,000 2.671% | $16.00 | $7.6M | -12.48% | ||
| 2020-12-23 | EVNIN LUKE | 15.88M – | $0 | $0 | ||||
| 2020-12-23 | Asanuma Sakae | 7.6M – | $0.46 | $3.5M | ||||
| 2020-12-23 | Lazarus Alon | 7.12M – | $8.00 | $56.97M |
Insider Historical Profitability
| GADICKE ANSBERT | 10 percent owner | 6672183 18.4354% | $2.34 | 1 | 0 | <0.0001% |
| RA CAPITAL MANAGEMENT, L.P. | director | 5701056 15.7521% | $2.34 | 5 | 0 | +3.88% |
| EVNIN LUKE | 4284172 11.8372% | $2.34 | 2 | 0 | <0.0001% | |
| MPM BioVentures 2014, L.P. | 10 percent owner | 3187998 8.8085% | $2.34 | 1 | 0 | <0.0001% |
| Flynn James E | 10 percent owner | 2552787 7.0534% | $2.34 | 1 | 0 | <0.0001% |
| Asanuma Sakae | 2068909 5.7164% | $2.34 | 2 | 0 | <0.0001% | |
| Taiho Ventures LLC | 10 percent owner | 2068909 5.7164% | $2.34 | 1 | 0 | <0.0001% |
| Lazarus Alon | 2046634 5.6549% | $2.34 | 2 | 0 | <0.0001% | |
| Arkin Bio Ventures 2 L.P. | 10 percent owner | 2046634 5.6549% | $2.34 | 1 | 0 | <0.0001% |
| Longwood Fund III GP, LLC | 10 percent owner | 1677082 4.6338% | $2.34 | 1 | 0 | <0.0001% |
| Sphera Global Healthcare Management LP | 10 percent owner | 787997 2.1773% | $2.34 | 1 | 0 | <0.0001% |
| Leonard Reid | Chief Operating Officer | 122157 0.3375% | $2.34 | 0 | 1 |
Institutional Investor Ownership
| RA Capital Management, L.P. | $39.82M | 14.14 | 6.14M | 0% | +$0 | 0.04 | |
| MPM Asset Management LLC | $27.76M | 9.86 | 4.28M | 0% | +$0 | 11.32 | |
| PFM Health Sciences | $19.48M | 6.92 | 3.01M | -13.3% | -$2.99M | 0.54 | |
| Adage Capital Partners Gp L L C | $19.44M | 6.91 | 3M | -1.11% | -$218,123.28 | 0.04 | |
| Bioimpact Capital Llc | $15.47M | 5.5 | 2.39M | 0% | +$0 | 2.51 | |
| Bank of America | $12.19M | 4.33 | 1.88M | -10.26% | -$1.39M | <0.01 | |
| Janus Henderson | $10.92M | 3.89 | 1.69M | New | +$10.92M | 0.01 | |
| Helm Capital Management LLC | $10.5M | 3.73 | 1.62M | -16.24% | -$2.04M | 0.31 | |
| The Vanguard Group | $7.18M | 2.55 | 1.11M | +26.78% | +$1.52M | <0.0001 | |
| Monashee Investment Management LLC | $5.77M | 2.05 | 890,000 | New | +$5.77M | 0.5 | |
| Eagle Health Investments Lp | $4.54M | 1.61 | 700,000 | New | +$4.54M | 0.86 | |
| Sphera Fund | $4.06M | 1.44 | 626,810 | 0% | +$0 | 0.67 | |
| Dc Funds Lp | $3.82M | 1.36 | 589,102 | 0% | +$0 | 36.89 | |
| Verition Fund Management Llc | $3.7M | 1.32 | 571,466 | New | +$3.7M | 0.04 | |
| Millennium Management LLC | $3.66M | 1.3 | 565,417 | +27.24% | +$784,455.81 | <0.01 | |
| Geode Capital Management | $1.68M | 0.6 | 259,680 | +33.64% | +$423,694.29 | <0.0001 | |
| Two Sigma Advisers LP | $1.6M | 0.57 | 247,600 | +39.65% | +$455,544.00 | <0.01 | |
| Alyeska Investment Group L P | $1.53M | 0.54 | 235,705 | -45.9% | -$1.3M | 0.01 | |
| Laurion Capital Management LP | $1.3M | 0.46 | 201,236 | +154.04% | +$790,708.87 | 0.04 | |
| Two Sigma | $1.2M | 0.43 | 185,059 | +26.12% | +$248,332.97 | <0.01 | |
| Susquehanna International Group | $1.14M | 0.41 | 175,798 | +1,089.67% | +$1.04M | <0.01 | |
| Acadian Asset Management | $1.12M | 0.4 | 172,883 | +119.75% | +$609,795.23 | <0.01 | |
| Goldman Sachs | $1.12M | 0.4 | 172,794 | New | +$1.12M | <0.0001 | |
| BlackRock | $1.07M | 0.38 | 164,792 | +128.16% | +$599,814.63 | <0.0001 | |
| Jane Street Capital | $1.02M | 0.36 | 157,226 | +985.29% | +$924,948.28 | <0.01 | |
| Qube Research & Technologies | $758,244.00 | 0.27 | 117,013 | +4,808.26% | +$742,795.69 | <0.01 | |
| Dimensional Fund Advisors | $723,329.00 | 0.26 | 111,625 | +77.4% | +$315,588.52 | <0.0001 | |
| Bridgeway Capital Management | $551,357.00 | 0.2 | 85,086 | 0% | +$0 | 0.01 | |
| Renaissance Technologies | $546,000.00 | 0.19 | 84,200 | -21.68% | -$151,129.17 | <0.01 | |
| Man Group Plc | $516,061.00 | 0.18 | 79,639 | New | +$516,061.00 | <0.01 | |
| Citigroup | $463,683.00 | 0.17 | 71,556 | New | +$463,683.00 | <0.0001 | |
| State Street | $461,169.00 | 0.16 | 71,168 | -14.74% | -$79,704.06 | <0.0001 | |
| JPMorgan Chase | $461,272.00 | 0.16 | 71,184 | +85,663.85% | +$460,734.16 | <0.0001 | |
| Edgewood Management | $324,000.00 | 0.12 | 50,000 | 0% | +$0 | <0.01 | |
| Northern Trust | $314,293.00 | 0.11 | 48,502 | -2.31% | -$7,426.08 | <0.0001 | |
| Cubist Systematic Strategies | $263,406.00 | 0.09 | 40,649 | New | +$263,406.00 | <0.01 | |
| Hrt Financial Llc | $243,000.00 | 0.09 | 37,628 | New | +$243,000.00 | <0.01 | |
| ROYCE & ASSOCIATES INC | $241,840.00 | 0.09 | 37,321 | New | +$241,840.00 | <0.01 | |
| Denali Advisors | $172,368.00 | 0.06 | 26,600 | New | +$172,368.00 | 0.05 | |
| Marshall Wace | $170,320.00 | 0.06 | 26,284 | New | +$170,320.00 | <0.0001 | |
| ExodusPoint Capital Management, LP | $164,000.00 | 0.06 | 25,240 | New | +$164,000.00 | <0.01 | |
| American Century Investments | $161,857.00 | 0.06 | 24,978 | New | +$161,857.00 | <0.0001 | |
| Squarepoint Ops LLC | $159,369.00 | 0.06 | 24,594 | New | +$159,369.00 | <0.01 | |
| Point72 Asia Singapore Pte Ltd | $150,751.00 | 0.05 | 23,264 | New | +$150,751.00 | 0.02 | |
| Raymond James Financial Services Advisors Inc | $153,310.00 | 0.05 | 23,659 | New | +$153,310.00 | <0.0001 | |
| Balyasny Asset Management Llc | $149,351.00 | 0.05 | 23,048 | New | +$149,351.00 | <0.0001 | |
| Morgan Stanley | $133,352.00 | 0.05 | 20,579 | +3,329.83% | +$129,464.00 | <0.0001 | |
| Brevan Howard Capital Management Lp | $122,537.00 | 0.04 | 18,910 | New | +$122,537.00 | 0.01 | |
| Y Intercept Hong Kong Ltd | $91,718.00 | 0.03 | 14,154 | New | +$91,718.00 | 0.01 | |
| Hbk Sorce Advisory Llc | $85,711.00 | 0.03 | 13,227 | -50% | -$85,711.00 | <0.01 |